Fetch.ai recently completed an important network update under Proposal 33, successfully integrating its mainnet with the CUDOS network. This integration unifies all CUDOS tokens and staked assets according to set token ratios, adding significant functionality to the Fetch.ai ecosystem with a three-month locking program.
Network Integration Brings Enhanced Interoperability
With this integration, Fetch.ai now benefits from an additional layer of interoperability. This move broadens Fetch.ai’s decentralized computing capabilities, enabling it to support more scalable and efficient AI and blockchain-based applications.
Partnership with Injective and Cross-Chain Potential
Fetch.ai’s latest partnership with Injective presents new developments in cross-chain interoperability. Through this collaboration, Fetch.ai has started utilizing Injective’s light client technology within the Inter-Blockchain Communication (IBC) protocol. This enhancement enables faster and more efficient asset transfers between the two networks, creating exciting new possibilities in decentralized applications.
Market Reaction and Analysts’ Views
Fetch.ai has seen a significant increase in market activity, with trading volume surging by 93.89% to $121.26 million, and open interest rising by 3.22%. This spike signals renewed investor interest in Fetch.ai.
Technical analyst “World of Charts” has observed that FET has broken out of its downtrend, indicating a potential reversal. If this breakout holds, FET could reach $5 in the short term. Meanwhile, crypto analyst DamiDefi predicts that with the impact of this technical breakout, increased trading volume, and successful updates, FET could climb as high as $13.
Fetch.ai’s recent network upgrade and partnership with Injective have contributed significantly to its ecosystem. With rising trading volume and favorable analyst predictions, Fetch.ai shows strong growth potential. As reported by Dey There, users and investors are closely monitoring these developments and their impact on FET’s value.
Fetch.ai, CUDOS, Injective, interoperability, trading volume
